HOME / Notice / News / EN
Despite the delay due to not enough supply of the materials caused by COVID-19 crisis, the construction of ‘NK Cell GMP Automated Cultivation System’ is running smoothly according to the schedule. We share some of the footages of the construction site. NKCL Bio Group’s Automated Cultivation Center...
NKCL Bio Group Inc. (hereinafter referred to as ‘NKCL Bio Group’) is a Korean Bio Group company that researches and develops NK Immune cell treatment which utilizes NK immune cells. With its competitive technologies including cancer cell target treatment and Automatic NK Cell Cultivation System,...
NKCL Bio group Inc. (hereinafter referred to as NKCL Bio Group) is a Korean bio company that researches and develops NK immune cell treatment using NK immune cell with its competitive technology. Last year, it had laid the foundation for popularizing NK immune cell treatment by opening the constructi...
Source: [Medical Observer] http://www.monews.co.kr/news/articleView.html?idxno=207654 “Enforcement ordinance for Advanced Regenerative Bio Law will be prepared in February” “We need to move beyond the bio-similar to the original developing phase”, said Kang Soek-Yeon, director of Biopharmaceutica...
Through the main sponsorship of Oscars Viewing Awards, NKCL declared its global marketing to the world. On February 9th, NKCL Bio Group Inc., declared its debut to the global market as the main sponsor of Oscars Viewing Awards, which was held in Hollywood, LA. Shin Donghwa, the Chairman of NKCL Bio G...